• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. the role that ACR Ped-30,50,70 played in evaluating the clinical efficacy of TNF antagonists in the

the role that ACR Ped-30,50,70 played in evaluating the clinical efficacy of TNF antagonists in the

来源 :中华医学生物免疫学会第二届学术年会 | 被引量 : 0次 | 上传用户：kejianghaoxl
【摘 要】
：
Objective:Using the ACR Ped-30,50,70 to assess the clinical efficacy of tumor necrosis factor antagonist in refractory systemic juvenile idiopathic arthritis (So-JIA).Methods:Evaluate the 30 refractor
【作 者】
：
曾萍 曾华松 谢颖 唐盈 王敏 
【机 构】
：
广州市妇女儿童医疗中心过敏免疫风湿病科
【出 处】
：
中华医学生物免疫学会第二届学术年会
【发表日期】
：
2014年5期
【关键词】
：
TNF antagonist juvenile idiopathic arthritis 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective:Using the ACR Ped-30,50,70 to assess the clinical efficacy of tumor necrosis factor antagonist in refractory systemic juvenile idiopathic arthritis (So-JIA).Methods:Evaluate the 30 refractory SO-JIA patients that achieved TNF antagonists using ACR Ped-30,50,70.The evaluation will carry out after treatment of 1 month,3 months and 6 months.Several indicators will be evulate,insist:(1)the dosage of the hormone.(2)the body temperature (3)count of active inflammatory joint (4)blood sedimentation (ESR) or c-reactive protein (CRP).
其他文献
A clinical trial on anti-HBV-DC combined with lamivudine and thymosin -a1 in the HBeAg positive pati
Background and aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells(DC) originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with la
会议
A clinical trial on anti-HBV-DC vaccine combined with thymosin-α 1 in the HBeAg negative patients of
Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with thymosin-α 1,in the H
会议
The clinical features of juvenile idiopathic arthritis and efficacy analysis of tumor necrosis facto
Objective Observe the cIinical effects and features of tumor necrosis factor antagonists (Etanercept) in treatment of systemic onset juvenile idiopathic arthritis (So-JIA),to provide the basis evidenc
会议
The changes and significances of serum IL-6 and IL-15 level in juvenile rheumatoid arthritis
Objective:Analyze the changes and significance of serum IL-6,IL-15 level in juvenile rheumatoid arthritis patients.Methods:Collect serum samples of 31 cases of juvenile rheumatoid arthritis children a
会议
juvenile rheumatoid arthritisIL-6IL-15
Discussion the correlation of anaphylactoid purpura children in gastrointestinal lesions and helicob
Objective:To explore the correlation of changes in gastrointestinal endoscopy change and helicobacter pylori infection of children with allergic purpura.Methods:Electronic endoscopy for 87 cases of al
会议
Allergic purpuraHastroscopyHelicobacter pylori
The clinical observation of immunoadsorption in treatment of children with refractory autoimmune dis
Objective:Explore the clinical efficacy and safety of the immunoadsorption assisted treatment of children with refractory autoimmune diseases.Methods:Use HA280 type resin perfusion machine for four ti
会议
Immunity adsorptionAllergic purpuraJuvenile idiopathic arthritisDermatomyosit
Early diagonostic and predictive value of antikeration antibody,anti-cyclic citryllinated peptide an
Objective To investigate the value of antikeration antibody (AKA),anti-cyclic citrullinated peptide antibody (antiCCP) and rheumatoid factor (RF-IgG,RF-IgM) in early diagnosis and prediction of juveni
会议
antikeratin antibodyanti-cyclic citrullinated peptide antibodyrheumatoid facto
The significance of early diagnosis and prognostic evaluation of four kinds of anti-CCP antibodies i
Objective:Investigate the relationship between immunological parameters AKA,anti-CCP,the RF-IGG,RF-IGM and the early diagnosis and prognosis in sub-JIA patients.Methods:Collection of 76 JIA patients i
会议
AKAanti-CCPRF-IGGRF-IGMjuvenile idiopathic arthritisearly diagnosisprognos
A randomized controlled clinical trial to evaluate the efficacy of Recombinant Human Tumor Necrosis
Objective:Research the Recombinant Human Tumor Necrosis Factor-α Receptor type Ⅱ fusion protein antibody (Etanercept)for Treatment of juvenile idiopathic arthritis (JIA).A randomized double-blind cont
会议
recombinant human tumor necrosis factor-α receptor type-Ⅱ fusion protein antibod
Efficacy and safety of Infliximab in juvenile idiopathic arthritis and juvenile ankylosing spondylit
objective :The randomized method was designed to observe the efficacy and safety ofinfliximab for juvenile idiopathic arthritis (JIA) and juvenile ankylosing spondylitis (JAS).This study will provide
会议
juvenile idiopathic arthritisjuvenile ankylosing spondylitisinfliximab